Orchestra

Orchestra

x

x

Use your exclusive MBC resident offer to connect scientific and financial planning to operations with Orchestra

Book a demo

  • Euler
    Biologics

Orchestra helps biotech founders connect scientific planning with finance and operations

Orchestra helps biotech founders connect scientific planning with finance and operations

Q2 2025 board meeting

Base case

Sources

Tables

Charts

Base case

cash out

Feb 2026

Sep 2026

total burn

$30,247,923

$26,963,436

average monthly burn

$772,219

$691,370

ending cash

$17,482,592

$14,509,558

H1 2025

H2 2025

H1 2026

H2 2026

H1 2027

H2 2027

Antibody program 001

Lead ID

🎯

DC Selection

🥇

Stable pools

🧬

Go for GLP Tox

🐭

Go for GMP

🏭

IND

🏛️

Go to Phase 1

💉

Antibody program 004

Phase 1 Acceleration

Go for GMP

🏭

Comparability done

🐭

IND

🏛️

-3 months

Go to Phase 1

💉

-3 months

End of Phase 1

🏥

-3 months

Finances

$25M

$20M

$15M

$10M

Last actual

Cash out

Base case: Projected cash balance

Base scenario: Cumulative spend

TODAY

Q2 2025 board meeting

Base case

Sources

Tables

Charts

Base case

cash out

Feb 2026

Sep 2026

total burn

$30,247,923

$26,963,436

average monthly burn

$772,219

$691,370

ending cash

$17,482,592

$14,509,558

H1 2025

H2 2025

H1 2026

H2 2026

H1 2027

H2 2027

Antibody program 001

Lead ID

🎯

DC Selection

🥇

Stable pools

🧬

Go for GLP Tox

🐭

Go for GMP

🏭

IND

🏛️

Go to Phase 1

💉

Antibody program 004

Phase 1 Acceleration

Go for GMP

🏭

Comparability done

🐭

IND

🏛️

-3 months

Go to Phase 1

💉

-3 months

End of Phase 1

🏥

-3 months

Finances

$25M

$20M

$15M

$10M

Last actual

Cash out

Base case: Projected cash balance

Base scenario: Cumulative spend

TODAY

Q2 2025 board meeting

Base case

Sources

Tables

Charts

Base case

cash out

Feb 2026

Sep 2026

total burn

$30,247,923

$26,963,436

average monthly burn

$772,219

$691,370

ending cash

$17,482,592

$14,509,558

H1 2025

H2 2025

H1 2026

H2 2026

H1 2027

H2 2027

Antibody program 001

Lead ID

🎯

DC Selection

🥇

Stable pools

🧬

Go for GLP Tox

🐭

Go for GMP

🏭

IND

🏛️

Go to Phase 1

💉

Antibody program 004

Phase 1 Acceleration

Go for GMP

🏭

Comparability done

🐭

IND

🏛️

-3 months

Go to Phase 1

💉

-3 months

End of Phase 1

🏥

-3 months

Finances

$25M

$20M

$15M

$10M

Last actual

Cash out

Base case: Projected cash balance

Base scenario: Cumulative spend

TODAY

01

Strategic planning
Strategic planning
Strategic planning

What milestones do I need to hit to reach IND on time?

Translate company strategy to centralized R&D roadmap


02

Intelligent operations
Intelligent operations
Intelligent operations

Do I have the resources to run GMP manufacturing?

Price out decisions across timeline, money, and milestones

03

Scenario modeling
Scenario modeling
Scenario modeling

How would our plans change if we raise $30M instead of $20M?

Automatic visualization of timelines, dependencies, and risks

Blog

Login

Contact

Contact

Blog

Login

Contact